2012
DOI: 10.2174/138945012802002410
|View full text |Cite
|
Sign up to set email alerts
|

Bacterial Cell Wall Compounds as Promising Targets of Antimicrobial Agents I. Antimicrobial Peptides and Lipopolyamines

Abstract: The first barrier that an antimicrobial agent must overcome when interacting with its target is the microbial cell wall. In the case of Gram-negative bacteria, additional to the cytoplasmic membrane and the peptidoglycan layer, an outer membrane (OM) is the outermost barrier. The OM has an asymmetric distribution of the lipids with phospholipids and lipopolysaccharide (LPS) located in the inner and outer leaflets, respectively. In contrast, Gram-positive bacteria lack OM and possess a much thicker peptidoglyca… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
30
0
2

Year Published

2012
2012
2024
2024

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 75 publications
(38 citation statements)
references
References 60 publications
2
30
0
2
Order By: Relevance
“…Thus, human binding proteins, such as LPS binding protein (LBP) and CD14, are impeded from binding to LPS epitopes, the charged head groups, and thus cannot initiate the inflammatory reaction. It has been found, furthermore, that the peptides still exert their effect when they are added in a time-delayed mode, i.e., when they are administered up to 3 hours after LPS addition [36]. This observation is indicative of a membrane process of the interaction, in accordance with recent findings that the peptides readily intercalate into membranes made from phosphatidylcholine and phosphatidylserine as characteristic of eukaryotic cells [34].…”
Section: Development and Anti-lps Effects Of Synthetic Antimicrobial supporting
confidence: 82%
“…Thus, human binding proteins, such as LPS binding protein (LBP) and CD14, are impeded from binding to LPS epitopes, the charged head groups, and thus cannot initiate the inflammatory reaction. It has been found, furthermore, that the peptides still exert their effect when they are added in a time-delayed mode, i.e., when they are administered up to 3 hours after LPS addition [36]. This observation is indicative of a membrane process of the interaction, in accordance with recent findings that the peptides readily intercalate into membranes made from phosphatidylcholine and phosphatidylserine as characteristic of eukaryotic cells [34].…”
Section: Development and Anti-lps Effects Of Synthetic Antimicrobial supporting
confidence: 82%
“…Th us, human binding proteins, such as LPS binding protein (LBP) and CD14, are impeded from binding to LPS epitopes, the charged head groups, and thus cannot initiate the infl ammatory reaction. It has been found, furthermore, that the peptides still exert their eff ect when they are added in a time-delayed mode, i.e., when they are administered up to 3 hours after LPS addition [36]. Th is observation is indicative of a membrane process of the interaction, in accordance with recent fi ndings that the peptides readily intercalate into membranes made from phosphatidylcholine and phosphatidylserine as characteristic of eukaryotic cells [34].…”
Section: Development and Anti-lps Eff Ects Of Synthetic Antimicrobialsupporting
confidence: 81%
“…The outer membrane is an advanced barrier shielding the bacterial cell against external antimicrobial compounds (53). To achieve the target cytoplasmic membrane, antimicrobial agents must overcome the barrier of the outer membrane in Gram-negative bacteria (54). This involves displacement of divalent cations from their binding sites on cell wall lipopolysaccharides (LPS) and the consequent permeabilization of the outer membrane (37).…”
mentioning
confidence: 99%